NIH and partners launch HIV vaccine efficacy study

The National Institutes of Health and partners have launched a large clinical trial to assess whether an experimental HIV vaccine regimen is safe and able to prevent HIV infection. The new Phase 2b proof-of-concept study, called Imbokodo, aims to enroll 2,600 HIV-negative women in sub-Saharan Africa. Of 1.8 million new HIV infections worldwide in 2016,

December 1st, 2017|Categories: Clinical Trials, HIV|Tags: , |

Making bone marrow transplants safer

New approach would use antibodies rather than radiation and chemotherapy June 7, 2016 | Editor's Pick Popular  By Hannah L. Robbins, Harvard Stem Cell Institute B.D. Colen/Harvard Stem Cell Institute Communications Rahul Palchaudhuri (left), postdoctoral fellow, and David Scadden, co-director of the Harvard Stem Cell Institute, look at real-time images of blood stem cells settling

Researchers Discover A New Mechanism of Proteins to Block HIV

Certain IFITM proteins block and inhibit cell-to-cell transmission of HIV Sept. 25, 2015 By Sheena Rice COLUMBIA, Mo. – There is little doubt that the Human Immunodeficiency Virus, or HIV, is devastating. More than 1.2 million people in the United States are living with HIV and more than 47,000 people are diagnosed annually. Now, University of

September 25th, 2015|Categories: Around The State, HIV|Tags: , , |

Scientists Say Fetal Tissue Essential for Medical Research

Wed, 08/12/2015 - 10:00am Collin Binkley and Carla K. Johnson, Associated Press In this Aug. 10, 2015, photo, Dr. Akhilesh Pandey, a researcher at Johns Hopkins University, poses alongside a mass spectrometer in his laboratory in Baltimore. Pandey's research analyzes both adult and fetal tissue, and by identifying which proteins are present, he can get

Magnetic Nanoparticles Could Be Key To Effective Immunotherapy

New method moves promising strategy closer to clinical use Release Date: July 15, 2015 FAST FACTS: Immunotherapy is based on the idea of training the body’s own immune cells to better combat cancer, infections and other diseases. A major challenge to its success has been the inability to produce enough trained immune cells to have

Scientists Unravel Elusive Structure of HIV Protein

June 30, 2015 by Jeff Sossamon COLUMBIA, Mo. – HIV, or human immunodeficiency virus, is the retrovirus that leads to acquired immunodeficiency syndrome or AIDS. Globally, about 35 million people are living with HIV, which constantly adapts and mutates creating challenges for researchers. Now, scientists at the University of Missouri are gaining a clearer idea of what

Stem cell gene therapy developed at UCLA holds promise for eliminating HIV infection

Method modifies immune cells to attack the virus, could be used to treat other diseases Mirabai Vogt-James | June 30, 2015 UCLA Broad Stem Cell Research CenterThe scientists, led by Jerome Zack (left) and Scott Kitchen, found that the technique decreased HIV levels in mice by 80 to 95 percent. Scientists at the UCLA Eli and

Wild chimps teach scientists about gene that encodes HIV-fighting protein

Part of a gene variant present in some wild African chimps is nearly identical to a section of an analogous gene version found in HIV-infected humans who are uncharacteristically slow to progress to full-blown AIDS. MAY 282015 Stanford researchers discovered that some of the chimpanzees in the Gombe Stream National Park, made famous by primatologist